Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Journal article |
| Vydáno: |
1998
|
| _version_ | 1826257337858392064 |
|---|---|
| author | Isaacs, J Greer, S Symmons, D Sharma, S Hale, G Waldmann, H Hazleman, B |
| author_facet | Isaacs, J Greer, S Symmons, D Sharma, S Hale, G Waldmann, H Hazleman, B |
| author_sort | Isaacs, J |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:16:36Z |
| format | Journal article |
| id | oxford-uuid:04d2f70a-34b5-4d18-90c9-98d5b7398f27 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:16:36Z |
| publishDate | 1998 |
| record_format | dspace |
| spelling | oxford-uuid:04d2f70a-34b5-4d18-90c9-98d5b7398f272022-03-26T08:53:51ZSurvival of patients after lymphocytotoxic monoclonal antibody therapy for RA.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:04d2f70a-34b5-4d18-90c9-98d5b7398f27Symplectic Elements at Oxford1998Isaacs, JGreer, SSymmons, DSharma, SHale, GWaldmann, HHazleman, B |
| spellingShingle | Isaacs, J Greer, S Symmons, D Sharma, S Hale, G Waldmann, H Hazleman, B Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title | Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title_full | Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title_fullStr | Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title_full_unstemmed | Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title_short | Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA. |
| title_sort | survival of patients after lymphocytotoxic monoclonal antibody therapy for ra |
| work_keys_str_mv | AT isaacsj survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT greers survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT symmonsd survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT sharmas survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT haleg survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT waldmannh survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra AT hazlemanb survivalofpatientsafterlymphocytotoxicmonoclonalantibodytherapyforra |